Pnc Financial Services Group, Inc. Inmune Bio, Inc. Transaction History
Pnc Financial Services Group, Inc.
- $153 Billion
- Q2 2025
A detailed history of Pnc Financial Services Group, Inc. transactions in Inmune Bio, Inc. stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 37,715 shares of INMB stock, worth $96,550. This represents 0.0% of its overall portfolio holdings.
Number of Shares
37,715Holding current value
$96,550% of portfolio
0.0%Shares
2 transactions
Others Institutions Holding INMB
# of Institutions
95Shares Held
6.88MCall Options Held
317KPut Options Held
104K-
Praetorian Pr LLC Rincon, PR865KShares$2.21 Million2.92% of portfolio
-
Vanguard Group Inc Valley Forge, PA827KShares$2.12 Million0.0% of portfolio
-
Black Rock Inc. New York, NY813KShares$2.08 Million0.0% of portfolio
-
Cvi Holdings, LLC Wilmington, DE596KShares$1.53 Million45.87% of portfolio
-
Geode Capital Management, LLC Boston, MA390KShares$998,2230.0% of portfolio
About Inmune Bio, Inc.
- Ticker INMB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 17,946,000
- Market Cap $45.9M
- Description
- INmune Bio, Inc., a clinical-stage immunotherapy company, focuses on developing drugs to reprogram the patient's innate immune system to treat disease. The company develops and commercializes product candidates to treat hematologic malignancies, solid tumors, and chronic inflammation. Its development programs include INKmune, which focuses on tr...